Marek Cezary Chawarski, PhD

Associate Professor of Psychiatry and of Emergency Medicine

Research Interests

China; Malaysia; Opioid-Related Disorders; Psychiatry; Risk-Taking; Russia; Substance Abuse Detection; Amphetamine-Related Disorders

Research Organizations

Psychiatry: Addictions, Division of | Connecticut Mental Health Center | Psychology Section

Faculty Research

Office of Cooperative Research

Research Summary

My research aims to improve efficacy, accessibility, and availability of treatments for substance use disorders and HIV risk reduction and prevention interventions in diverse settings and populations. My recent work focuses on the development of behavioral counseling programs that target high-risk individuals; addressing their limited understanding of substance use problems, substance use disorders, and effective treatment and recovery strategies, aimed at increasing their treatment engagement, helping them to transfer treatment-learned skills into real-life situations, and reducing their risks of HIV and other infectious diseases.

Specialized Terms: Substance Use Disorders; Opioids; Amphetamine Type Stimulants ; Risk Behaviors; Psychiatry; Psychology

Extensive Research Description

My primary research interest is in developing novel treatment interventions for patients with substance use disorders, in particular for individuals using opioids and/or amphetamine type stimulants. I am involved in multiple international research efforts to improve treatments of substance use disorders, with emphasis on culturally appropriate evidence-based treatments. My teaching and educational efforts are focused on training therapists, drug counselors, and other medical and non-medical personnel in providing behaviorally oriented psychosocial interventions for patients receiving medication assisted treatments, or other forms of pharmacological and drug-free treatments for opioid and/or amphetamine type simulant use disorders.

I am currently the principal investigator on two collaborative international studies:



A study entitled "Behavioral

Drug and HIV Risk Reduction Counseling with MMT in China" will provide critical data

regarding the efficacy for reducing drug-and sex-related HIV transmission risk

behaviors, as well as improving MMT outcomes and patient functioning of two

transportable counseling models, behavioral drug and HIV risk reduction

counseling (BDRC) and educational counseling (EC) as compared with the current

standard of care model in MMT in China. Supported by NIDA/NIH grant R01 DA026797.



A study entitled "Naltrexone and Behavioral Drug and HIV Risk

Reduction Counseling in Russia" will

examine the effects of combining behavioral therapy with naltrexone

pharmacotherapy for the treatment of opiate dependence and reduction of HIV

risks in opiate dependent individuals in St.

Petersburg, Russia. Supported by NIDA/NIH grant R01 DA 27405.

Selected Publications

Edit this profile

Contact Info

Marek Cezary Chawarski, PhD
Mailing Address
Yale University School of MedicineCMHC/SAC
34 Park Street

New Haven, CT 06519